BGIM
ITCI
Brandywine Global Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-31,532
| Closed | -$1.47M | – | 794 |
|
|
2022
Q3 | $1.47M | Hold |
31,532
| – | – | 0.01% | 581 |
|
|
2022
Q2 | $1.8M | Sell |
31,532
-537,279
| -94% | -$30.7M | 0.02% | 553 |
|
|
2022
Q1 | $34.8M | Sell |
568,811
-6,167
| -1% | -$377K | 0.25% | 115 |
|
|
2021
Q4 | $30.1M | Sell |
574,978
-10,096
| -2% | -$528K | 0.22% | 129 |
|
|
2021
Q3 | $21.8M | Buy |
585,074
+389,514
| +199% | +$14.5M | 0.16% | 146 |
|
|
2021
Q2 | $7.98M | Buy |
+195,560
| New | +$7.98M | 0.06% | 318 |
|
|
2020
Q1 | – | Sell |
-65,619
| Closed | -$2.17M | – | 887 |
|
|
2019
Q4 | $2.17M | Buy |
65,619
+8,062
| +14% | +$267K | 0.02% | 523 |
|
|
2019
Q3 | $430K | Sell |
57,557
-13,312
| -19% | -$99.5K | ﹤0.01% | 590 |
|
|
2019
Q2 | $920K | Buy |
70,869
+28,409
| +67% | +$369K | 0.01% | 577 |
|
|
2019
Q1 | $518K | Buy |
+42,460
| New | +$518K | ﹤0.01% | 571 |
|